During the past decade, Haematologisch Onkologische Praxis conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Haematologisch Onkologische Praxis" are "Lymphoma" (4 trials) and "Leukemia" (1 trials). Many other conditions were trialed in "Haematologisch Onkologische Praxis" in a lesser frequency.

Most popular intervention types in "Haematologisch Onkologische Praxis" are "Biological" (5 trials), "Drug" (5 trials), "Radiation" (4 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (5 trials), "doxorubicin hydrochloride" (4 trials), "prednisone" (4 trials), "radiation therapy" (4 trials) and "vincristine sulfate" (4 trials). Other intervention names were less common.

The vast majority of trials in "Haematologisch Onkologische Praxis" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Haematologisch Onkologische Praxis". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Haematologisch Onkologische Praxis, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Haematologisch Onkologische Praxis, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".